CASC3 and primary cutaneous T-cell non-Hodgkin lymphoma: We were able to partially overcome the suppression using HSAP5/6 selective inhibitors and Btz, which we also showed could block Th2 cytokine production, demonstrating causality between ER stress and effectors of the UPR and the immunosuppressive phenotype of CTCL.